Depression and Anxiety Trial, Recruiting (NCT06835907)

Depression and Anxiety Trial, Recruiting NCT06835907 Sponsor: Universitair Ziekenhuis Brussel Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT06835907 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Alcohol Use Disorder (a recognized pattern of problematic alcohol use) according to standard medical guidelines
You are able to understand the study information and sign a consent form agreeing to take part
You are already taking a medication called baclofen, or you started taking it at the beginning of a hospital stay
You have a personal goal of stopping drinking alcohol completely

Who may not be able to join:

You have a dependency or disorder related to other substances (apart from nicotine or cannabis)
You have a significant mental health condition that requires medication, unless it has been stable with no changes to your medication in the last 30 days (confirm with trial site)
You have a serious medical condition that could make it unsafe for you to continue taking baclofen (confirm with trial site)
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cleo L Crunelle, Universitair Ziekenhuis Brussel

Phone: +32 477 77 22

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06835907

Sponsor: Universitair Ziekenhuis Brussel

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: +32 477 77 22

More information: https://clinicaltrials.gov/study/NCT06835907

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Alcohol Use Disorder (a recognized pattern of problematic alcohol use) according to standard medical guidelines
You are able to understand the study information and sign a consent form agreeing to take part
You are already taking a medication called baclofen, or you started taking it at the beginning of a hospital stay
You have a personal goal of stopping drinking alcohol completely

Who may not be able to join:

You have a dependency or disorder related to other substances (apart from nicotine or cannabis)
You have a significant mental health condition that requires medication, unless it has been stable with no changes to your medication in the last 30 days (confirm with trial site)
You have a serious medical condition that could make it unsafe for you to continue taking baclofen (confirm with trial site)
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Universitair Ziekenhuis Brussel

Registry

ClinicalTrials.gov

Start date

28 October 2024

Est. completion

30 December 2029

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Number of days abstinent

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov